Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Rectum Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07811128
What this trial is testing

Leveraging Digital Health Solutions to Collect Patient-Reported Outcomes in Rectal Cancer

Who this might be right for
Rectal CancerNon Metastatic Rectal Cancer
University of California, San Francisco 150
Early research (Phase 1)Study completedNCT00027534
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerGallbladder Cancer+6 more
Michael Morse, MD 14
Testing effectiveness (Phase 2)Ended earlyNCT02216149
What this trial is testing

Effects of S-1 and Capecitabine on Coronary Artery Blood Flow

Who this might be right for
Esophagus CancerStomach CancerSmall Bowel Cancer+2 more
Heikki Joensuu 20
Testing effectiveness (Phase 2)Study completedNCT00217711
What this trial is testing

Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Colorectal Cancer
Swiss Cancer Institute 23
Testing effectiveness (Phase 2)UnknownNCT00496704
What this trial is testing

Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With Irinotecan

Who this might be right for
Colorectal Cancer
Yonsei University 56
Early research (Phase 1)UnknownNCT00392470
What this trial is testing

Radiation Therapy, Irinotecan, and Cetuximab in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Rectal Cancer

Who this might be right for
Colorectal Cancer
Centre Hospitalier Universitaire Vaudois 20
Testing effectiveness (Phase 2)Study completedNCT00080834
What this trial is testing

DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma

Who this might be right for
Colorectal Cancer
Daiichi Sankyo
Testing effectiveness (Phase 2)Study completedNCT01674309
What this trial is testing

First Line Treatment by FOLFIRINOX for Patients With a Rectum Cancer With Synchronous Non Resectable Metastasis

Who this might be right for
Adenocarcinoma of Rectum
Federation Francophone de Cancerologie Digestive 65
Not applicableNot Yet RecruitingNCT05129774
What this trial is testing

Chemoradiotherapy Sequenced Radical Surgery for Colorectal Cancer With PALNM

Who this might be right for
Colorectal Neoplasms MalignantLymph Node ExcisionChemoradiotherapy
Qilu Hospital of Shandong University 40
Not applicableStudy completedNCT01822444
What this trial is testing

ANGIOPREDICT. ICORG 12-16, V3

Who this might be right for
Advanced Colorectal Cancer
Cancer Trials Ireland 76
Testing effectiveness (Phase 2)Study completedNCT00557102
What this trial is testing

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung

Who this might be right for
Colorectal CancerMetastatic Cancer
National Cancer Institute, France 24
Early research (Phase 1)Study completedNCT00535353
What this trial is testing

AZD2281 and Irinotecan in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
NCIC Clinical Trials Group 26
Large-scale testing (Phase 3)Study completedNCT00265824
What this trial is testing

Optimized Chemotherapy Followed by Maintenance With Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Colorectal Cancer That Cannot be Removed by Surgery (DREAM)

Who this might be right for
Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 700
Not applicableNot Yet RecruitingNCT07211230
What this trial is testing

Collagenase Biobank Study

Who this might be right for
Colorectal (Colon or Rectal) Cancer
University of Chicago 107
Large-scale testing (Phase 3)Study completedNCT00975897
What this trial is testing

Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Medical Research Council 3,240
Early research (Phase 1)Study completedNCT00280176
What this trial is testing

Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer

Who this might be right for
Colorectal Cancer
UNC Lineberger Comprehensive Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT02973672
What this trial is testing

Phase I of SGM-101 in Patients With Cancer of the Colon, Rectum or Pancreas

Who this might be right for
Colon CancerRectum CancerPancreas Cancer+2 more
Surgimab 75
Testing effectiveness (Phase 2)Study completedNCT00003995
What this trial is testing

Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2

Who this might be right for
Colorectal Cancer
National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Study completedNCT00016250
What this trial is testing

Ro 31-7453 in Treating Patients With Recurrent or Refractory Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00004087
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer

Who this might be right for
Colorectal CancerPancreatic Cancer
Garden State Cancer Center at the Center for Molecular Medicine and Immunology 15
Next Page